Congress Park Capital’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$184K Hold
49,171
0.05% 134
2026
Q1
$231K Sell
49,171
-9,751
-17% -$49.5K 0.07% 121
2025
Q4
$251K Sell
58,922
-45,000
-43% -$171K 0.07% 112
2025
Q3
$332K Buy
103,922
+8,500
+9% +$19.1K 0.1% 93
2025
Q2
$217K Sell
95,422
-578,264
-86% -$932K 0.07% 106
2025
Q1
$428K Sell
673,686
-290,904
-30% -$226K 0.16% 84
2024
Q4
$994K Sell
964,590
-251,418
-21% -$270K 0.36% 59
2024
Q3
$1.43M Buy
1,216,008
+62,788
+5% +$79.8K 0.53% 44
2024
Q2
$1.41M Buy
1,153,220
+919,420
+393% +$1.83M 0.57% 46
2024
Q1
$510K Sell
233,800
-5,500
-2% -$10.2K 0.23% 78
2023
Q4
$371K Buy
239,300
+126,850
+113% +$167K 0.18% 88
2023
Q3
$145K Buy
112,450
+6,300
+6% +$9.92K 0.08% 113
2023
Q2
$183K Buy
106,150
+5,950
+6% +$9.88K 0.1% 126
2023
Q1
$151K Buy
+100,200
New +$226K 0.09% 130
2021
Q2
Sell
-20,207
Closed -$156K 142
2021
Q1
$156K Sell
20,207
-5,600
-22% -$44.3K 0.09% 125
2020
Q4
$169K Sell
25,807
-52,754
-67% -$377K 0.1% 110
2020
Q3
$522K Sell
78,561
-7,750
-9% -$57.5K 0.36% 59
2020
Q2
$719K Sell
86,311
-12,300
-12% -$114K 0.55% 43
2020
Q1
$756K Buy
98,611
+3,950
+4% +$27.5K 0.68% 35
2019
Q4
$787K Sell
94,661
-73,150
-44% -$494K 0.58% 39
2019
Q3
$1.24M Sell
167,811
-800
-0.5% -$7.89K 1.04% 28
2019
Q2
$1.72M Sell
168,611
-42,895
-20% -$450K 1.36% 24
2019
Q1
$2.27M Buy
211,506
+88,195
+72% +$1.3M 1.97% 16
2018
Q4
$1.86M Buy
123,311
+11,125
+10% +$165K 2.05% 15
2018
Q3
$2.08M Buy
112,186
+2,661
+2% +$60.6K 1.86% 15
2018
Q2
$2.5M Buy
109,525
+1,800
+2% +$46K 2.4% 10
2018
Q1
$3.06M Sell
107,725
-18,250
-14% -$521K 3.15% 6
2017
Q4
$2.66M Buy
+125,975
New +$2.61M 2.68% 7

Other funds holding CTMX